A randomized placebo-controlled trial of infliximab therapy for active ulcerative colitis: ACT 1 trial

被引：0
|
作者：
Rutgeerts, P
Feagan, BG
Olson, A
Johanns, J
Travers, S
Present, D
Sands, BE
Sandborn, W
Olson, A
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A105 / A105
页数：1
相关论文
共 50 条
  • [41] A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PSYLLIUM FIBER AND FECAL MICROBIOTA TRANSPLANTATION FOR MILD TO MODERATE ULCERATIVE COLITIS
    Gogokhia, Lasha
    Tran, Nancy
    Lavergne, Alexa
    Funez-dePagnier, Gabriela
    Xiang, Grace
    Warren, Ryan
    Nagayama, Manabu
    Scherl, Ellen
    Lukin, Dana
    Longman, Randy
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S9 - S9
  • [42] Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial
    Sajjad Moradi
    Reza Bagheri
    Parsa Amirian
    Mahsa Zarpoosh
    Neda Cheraghloo
    Alexei Wong
    Mehdi Zobeiri
    Mohammad Hassan Entezari
    BMC Complementary Medicine and Therapies, 24
  • [43] Curcumin Add-on Therapy for Remission Induction in Mild-moderate Active Ulcerative Colitis: A Multi-center, Randomized, Placebo-Controlled Trial
    Salomon, N.
    Lang, A.
    Kopylov, U.
    Lahat, A.
    Har-Noy, O.
    Wu, J.
    Ching, J.
    Cheong, P. K.
    Avidan, B.
    Gamus, D.
    Kaimaklotis, J.
    Eliakim, A.
    Ng, S. C.
    Ben-Horin, S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : 1381 - 1382
  • [44] A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis
    Schreiber, Stefan
    Keshavarzian, Ali
    Isaacs, Kim L.
    Schollenberger, John
    Guzman, Juan P.
    Orlandi, Cesare
    Hanauer, Stephen B.
    GASTROENTEROLOGY, 2007, 132 (01) : 76 - 86
  • [45] Oral Fluconazole Therapy in Patients With Active Ulcerative Colitis Who Have Detectable Candida in the Stool A Double-Blind Randomized Placebo-controlled Trial
    Jena, Anuraag
    Dutta, Usha
    Shah, Jimil
    Sharma, Vishal
    Prasad, Kaushal K.
    Shivaprakash, Rudramurthy M.
    Mandavdhare, Harshal S.
    Samanta, Jayanta
    Sharma, Pankaj
    Popli, Priyanka
    Sharma, Arun K.
    Sinha, Saroj K.
    Chakrabarti, Arunaloke
    Kochhar, Rakesh
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2022, 56 (08) : 705 - 711
  • [46] A Randomized, Double-Blind, Placebo-Controlled Trial of Budesonide for the Treatment of Active Lymphocytic Colitis
    Pardi, Darrell S.
    Loftus, Edward V.
    Tremaine, William J.
    Sandborn, William J.
    GASTROENTEROLOGY, 2009, 136 (05) : A519 - A520
  • [47] Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: A randomized placebo-controlled study
    Altun, Hulya Kamarli
    Yildiz, Emine Akal
    Akin, Mete
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 30 (04): : 313 - 320
  • [48] Three-antibiotic combination therapy in patients with active ulcerative colitis: A double-blind placebo-controlled multicenter trial
    Ohkusa, Toshifumi
    Kato, Kunitoshi
    Terao, Shuichi
    Chiba, Toshirm
    Mabe, KaLsuhiro
    Murakami, Kazunari
    Mizolcum, Yuji
    Takeuchi, Yoshiaki
    Sugiyama, Toshirc
    Kudo, Takahiko
    Yanaka, Akinori
    Yamato, Shigent
    Yokoyama, Tietsup
    Okayasu, Isao
    Sato, Nobuhiro
    Watanabe, Sumio
    GASTROENTEROLOGY, 2007, 132 (04) : A131 - A131
  • [49] Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial
    Libertucci, Josie
    Whelan, Fiona J.
    Moayyedi, Paul
    Lee, Christine H.
    Wolfe, Melanie
    Onishi, Catherine
    Marshall, John K.
    Armstrong, David
    Surette, Michael
    GASTROENTEROLOGY, 2014, 146 (05) : S902 - S902
  • [50] Infliximab for ulcerative colitis: The need for adequately powered placebo-controlled trials
    Rutgeerts, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (10): : 2488 - 2489
12345